-
2
-
-
0034820865
-
Abnormal coagulation in the postoperative period contributing to excessive bleeding
-
McKenna R. Abnormal coagulation in the postoperative period contributing to excessive bleeding. Med Clinic North Am 2001; 85: 1277-1310
-
(2001)
Med Clinic North Am
, vol.85
, pp. 1277-1310
-
-
McKenna, R.1
-
3
-
-
0031583322
-
Management of anticoagulation before and after elective surgery
-
Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med 1997; 336: 1506-1511
-
(1997)
N Engl J Med
, vol.336
, pp. 1506-1511
-
-
Kearon, C.1
Hirsh, J.2
-
4
-
-
0035673358
-
Practical management of anticoagulation, bleeding and blood product support for cardiac surgery. Part one: Bleeding and anticoagulation issues
-
Robinson KL, Marasco SF, Street AM. Practical management of anticoagulation, bleeding and blood product support for cardiac surgery. Part one: bleeding and anticoagulation issues. Heart, Lung and Circulation 2001; 10: 142-153
-
(2001)
Heart, Lung and Circulation
, vol.10
, pp. 142-153
-
-
Robinson, K.L.1
Marasco, S.F.2
Street, A.M.3
-
5
-
-
0027413840
-
Penicillin-induced dysfunction of platelet membran glycoproteins
-
Pastakia KB, Terle D, Prodouz KN. Penicillin-induced dysfunction of platelet membran glycoproteins. J Lab Clin Med 1993; 121: 546-554
-
(1993)
J Lab Clin Med
, vol.121
, pp. 546-554
-
-
Pastakia, K.B.1
Terle, D.2
Prodouz, K.N.3
-
6
-
-
0025255210
-
Beta-lactam antibiotic-induced platelet dysfunction: Evidence of irreversible inhibition of platelet activation in vitro and in vivo after prolonged exposure to penicillin
-
Burroughs SF, Johnson GJ. Beta-lactam antibiotic-induced platelet dysfunction: evidence of irreversible inhibition of platelet activation in vitro and in vivo after prolonged exposure to penicillin. Blood 1990; 75: 1473-1480
-
(1990)
Blood
, vol.75
, pp. 1473-1480
-
-
Burroughs, S.F.1
Johnson, G.J.2
-
7
-
-
0027743561
-
Effects of some cephalosporins and teicoplanin on platelet aggregation
-
Cazzola M, Matera MG, Santangelo G, Lampa E, Angrisani M, Loffreda A, Rossi F. Effects of some cephalosporins and teicoplanin on platelet aggregation. Int J Clin Pharmacol Res 1993; 13: 69-73
-
(1993)
Int J Clin Pharmacol Res
, vol.13
, pp. 69-73
-
-
Cazzola, M.1
Matera, M.G.2
Santangelo, G.3
Lampa, E.4
Angrisani, M.5
Loffreda, A.6
Rossi, F.7
-
8
-
-
0036250496
-
Antithrombin, heparin, and heparan sulfate
-
Opal SM, Kessler CM, Roemisch J, Knaub S. Antithrombin, heparin, and heparan sulfate. Crit Care Med 2002; 30 (suppl): S325-S331
-
(2002)
Crit Care Med
, vol.30
, Issue.SUPPL.
-
-
Opal, S.M.1
Kessler, C.M.2
Roemisch, J.3
Knaub, S.4
-
9
-
-
0035125405
-
Heparin and low-molecular-weight heparin: Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety
-
Hirsh J, Warkentin TE, Shaughnessy SG, Anand SS, Halperin JL, Raschke R, Granger C, Ohman EM, Dalen JE. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 2001; 119 Suppl: 64S-94S
-
(2001)
Chest
, vol.119
, Issue.SUPPL.
-
-
Hirsh, J.1
Warkentin, T.E.2
Shaughnessy, S.G.3
Anand, S.S.4
Halperin, J.L.5
Raschke, R.6
Granger, C.7
Ohman, E.M.8
Dalen, J.E.9
-
10
-
-
0036272614
-
Antikoagulation bei HIT II. Wann therapeutisch - Wann prophylaktisch?
-
Greinacher A. Antikoagulation bei HIT II. Wann therapeutisch - wann prophylaktisch? Anästhesiol Intensivmed Notfallmed Schmerzther 2002; 37 Suppl 1: 3-7
-
(2002)
Anästhesiol Intensivmed Notfallmed Schmerzther
, vol.37
, Issue.SUPPL.
, pp. 3-7
-
-
Greinacher, A.1
-
11
-
-
10744226520
-
Risk of postoperative hemorrhage after intracranial surgery after early nadroparin administration: Results of a prospective study
-
Gerlach R, Scheuer T, Beck J, Woszczyk A, Seifert V, Raabe A. Risk of postoperative hemorrhage after intracranial surgery after early nadroparin administration: results of a prospective study. Neurosurgery 2003; 53: 1028-1034
-
(2003)
Neurosurgery
, vol.53
, pp. 1028-1034
-
-
Gerlach, R.1
Scheuer, T.2
Beck, J.3
Woszczyk, A.4
Seifert, V.5
Raabe, A.6
-
13
-
-
0028052203
-
Protamine neutralization of intravenous and subcutaneous low-molecular-weight heparin (tinzaparin, Logiparin): An experimental investigation in healthy volunteers
-
Holst J, Lindblad B, Bergqvist D, Garre K, Nielsen H, Hedner U, Ostergaard PB. Protamine neutralization of intravenous and subcutaneous low-molecular-weight heparin (tinzaparin, Logiparin): An experimental investigation in healthy volunteers. Blood Coagul Fibrinolysis 1994; 5: 795-803
-
(1994)
Blood Coagul Fibrinolysis
, vol.5
, pp. 795-803
-
-
Holst, J.1
Lindblad, B.2
Bergqvist, D.3
Garre, K.4
Nielsen, H.5
Hedner, U.6
Ostergaard, P.B.7
-
14
-
-
0035119183
-
The effects of recent aspirin ingestion on platelet function in cardiac surgical patients
-
Gibbs NM, Weightman WM, Thackray NM, Michalopoulos N, Weidmann C. The effects of recent aspirin ingestion on platelet function in cardiac surgical patients. J Cardiothorac Vasc Anesth 2001; 15: 55-59
-
(2001)
J Cardiothorac Vasc Anesth
, vol.15
, pp. 55-59
-
-
Gibbs, N.M.1
Weightman, W.M.2
Thackray, N.M.3
Michalopoulos, N.4
Weidmann, C.5
-
15
-
-
0028922825
-
Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis
-
Schafer A. effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis. J Clin Pharmacol 1995; 35: 209-219
-
(1995)
J Clin Pharmacol
, vol.35
, pp. 209-219
-
-
Schafer, A.1
-
16
-
-
0029856157
-
Aspirin does not increase allogeneic blood transfusion in reoperative coronary artery surgery
-
Tuman KJ, McCarthy RJ, O'Connor CJ, McCarthy WE, Ivankovich AD. Aspirin does not increase allogeneic blood transfusion in reoperative coronary artery surgery. Anesth Analg 1996; 83: 1178-1184
-
(1996)
Anesth Analg
, vol.83
, pp. 1178-1184
-
-
Tuman, K.J.1
McCarthy, R.J.2
O'Connor, C.J.3
McCarthy, W.E.4
Ivankovich, A.D.5
-
17
-
-
0037898099
-
Lokoregionalanästhesie und blutgerinnung. Behandlung mit thrombozytenfunktionshemmern
-
Kozek-Langenecker SA. Lokoregionalanästhesie und Blutgerinnung. Behandlung mit Thrombozytenfunktionshemmern. Anaesthesist 2003; 52: 549-562
-
(2003)
Anaesthesist
, vol.52
, pp. 549-562
-
-
Kozek-Langenecker, S.A.1
-
18
-
-
0033665248
-
Effects of celcoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: A randomized, controlled trial
-
Leese P, Hubbard R, Karim A, Isakson PC, Yu SS, Geis GS. Effects of celcoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial. J Clin Pharmacol 2000; 40: 124-132
-
(2000)
J Clin Pharmacol
, vol.40
, pp. 124-132
-
-
Leese, P.1
Hubbard, R.2
Karim, A.3
Isakson, P.C.4
Yu, S.S.5
Geis, G.S.6
-
19
-
-
0037686389
-
Cyclooxygenase-2 inhibitors
-
Gajraj NM. Cyclooxygenase-2 inhibitors. Anesth Analg 2003; 96: 1720-1738
-
(2003)
Anesth Analg
, vol.96
, pp. 1720-1738
-
-
Gajraj, N.M.1
-
20
-
-
0037345662
-
Rückenmarksnahe regionalanästhesien und thromboembolieprophylaxe/antithrombotische medikation
-
Gogarten W, van Aken H, Büttner J, Riess H, Wulf H, Buerkle H. Rückenmarksnahe Regionalanästhesien und Thromboembolieprophylaxe/ antithrombotische Medikation. Anaesth Intensivmedizin 2003; 44: 218-230
-
(2003)
Anaesth Intensivmedizin
, vol.44
, pp. 218-230
-
-
Gogarten, W.1
Van Aken, H.2
Büttner, J.3
Riess, H.4
Wulf, H.5
Buerkle, H.6
-
21
-
-
0036484513
-
Is there a bleeding problem with platelet-active drugs?
-
Kövesi T, Royston D. Is there a bleeding problem with platelet-active drugs? Br J Anaesth 2002; 88: 159-163
-
(2002)
Br J Anaesth
, vol.88
, pp. 159-163
-
-
Kövesi, T.1
Royston, D.2
-
22
-
-
0036784839
-
Platelet glycoprotein IIb/IIIa inhibitors: Overview and implications for the anaesthesiologist
-
Chun R, Orser BA, Madan M. Platelet glycoprotein IIb/IIIa inhibitors: overview and implications for the anaesthesiologist. Anesth Analg 2002; 95: 879-888
-
(2002)
Anesth Analg
, vol.95
, pp. 879-888
-
-
Chun, R.1
Orser, B.A.2
Madan, M.3
-
23
-
-
0024215694
-
Correction of bleeding time after administration of desmopressin in a woman treated with ticlopidine
-
Nov 12
-
Calenda E, Papion H, Borg JY, Menguy E, Delaunay T, Watelet J, Testart J, Winkler C. Correction of bleeding time after administration of desmopressin in a woman treated with ticlopidine. Presse Med 1988 Nov 12; 17: 2143
-
(1988)
Presse Med
, vol.17
, pp. 2143
-
-
Calenda, E.1
Papion, H.2
Borg, J.Y.3
Menguy, E.4
Delaunay, T.5
Watelet, J.6
Testart, J.7
Winkler, C.8
-
24
-
-
0030715080
-
Danaparoid: A review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia
-
Wilde M, Markham A. Danaparoid: A review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia. Drugs 1997; 54: 903-924
-
(1997)
Drugs
, vol.54
, pp. 903-924
-
-
Wilde, M.1
Markham, A.2
-
25
-
-
0036231080
-
Fondaparinux - Ein synthetischer Faktor-Xa-Inhibitor
-
Lipp HP. Fondaparinux - ein synthetischer Faktor-Xa-Inhibitor. Krankenhauspharmazie 2002; 23: 141-148
-
(2002)
Krankenhauspharmazie
, vol.23
, pp. 141-148
-
-
Lipp, H.P.1
-
26
-
-
0037048939
-
Ximelagatran and megalatran compared with dalteparin for the prevention of venous thromboembolism after total hip or knee replacement. The METHRO II randomised trial
-
Eriksson BI, Bergqvist D, Kälebo P, Dahl OE, Lindbratt S, Bylock A, Frison L, Eriksson UG, Welin L, Gustafsson D. Ximelagatran and megalatran compared with dalteparin for the prevention of venous thromboembolism after total hip or knee replacement. The METHRO II randomised trial. Lancet 2002; 360: 1441-1447
-
(2002)
Lancet
, vol.360
, pp. 1441-1447
-
-
Eriksson, B.I.1
Bergqvist, D.2
Kälebo, P.3
Dahl, O.E.4
Lindbratt, S.5
Bylock, A.6
Frison, L.7
Eriksson, U.G.8
Welin, L.9
Gustafsson, D.10
-
27
-
-
0035251672
-
The direct thrombin inhibitor melagatran and its oral prodrug H 376/95: Intestinal absorption, biochemical and pharmacodynamic effects
-
Gustafsson D, Nyström J, Carlsson S. The direct thrombin inhibitor melagatran and its oral prodrug H 376/95: intestinal absorption, biochemical and pharmacodynamic effects. Thromb Res 2001; 101: 171-181
-
(2001)
Thromb Res
, vol.101
, pp. 171-181
-
-
Gustafsson, D.1
Nyström, J.2
Carlsson, S.3
-
28
-
-
0037256123
-
Influence of the age on the pharmacokinetics and pharmacodynamics of ximelagatran, an oral direct thrombin inhibitor
-
Johansson LC, Frison L, Logren U, Fager G, Gustafsson D, Eriksson UG. Influence of the age on the pharmacokinetics and pharmacodynamics of ximelagatran, an oral direct thrombin inhibitor. Clin Pharmacokinet 2003; 42: 382-392
-
(2003)
Clin Pharmacokinet
, vol.42
, pp. 382-392
-
-
Johansson, L.C.1
Frison, L.2
Logren, U.3
Fager, G.4
Gustafsson, D.5
Eriksson, U.G.6
-
29
-
-
0347694418
-
Melagatran und ximelagatran. Pharmakologische eigenschaften und anästhesiologische aspekte
-
Pindur G, Ziegeler S, Kleinschmidt S. Melagatran und Ximelagatran. Pharmakologische Eigenschaften und anästhesiologische Aspekte. Anaesthesist 2003; 52: 1171-1175
-
(2003)
Anaesthesist
, vol.52
, pp. 1171-1175
-
-
Pindur, G.1
Ziegeler, S.2
Kleinschmidt, S.3
-
30
-
-
0038732437
-
HIT/HITT and alternative anticoagulation: Current concepts
-
Pravinkumar E, Webster NR. HIT/HITT and alternative anticoagulation: current concepts. Brit J Anaesth 2003; 90: 676-685
-
(2003)
Brit J Anaesth
, vol.90
, pp. 676-685
-
-
Pravinkumar, E.1
Webster, N.R.2
-
31
-
-
0034945280
-
Herbal medicines and perioperativen care
-
Ang-Lee MK, Moss J, Yuan CS. Herbal medicines and perioperativen care. JAMA 2001; 286: 208-216
-
(2001)
JAMA
, vol.286
, pp. 208-216
-
-
Ang-Lee, M.K.1
Moss, J.2
Yuan, C.S.3
-
32
-
-
0036216530
-
Herbal medicine and anaesthesia
-
Cheng B, Hung CT, Chiu W. Herbal medicine and anaesthesia. HKMJ 2002; 8: 123-130
-
(2002)
HKMJ
, vol.8
, pp. 123-130
-
-
Cheng, B.1
Hung, C.T.2
Chiu, W.3
-
33
-
-
0029989628
-
The neuroprotective properties of the Gingko biloba leaf: A review of the possible relationship to platelet-activating factor (PAF)
-
Smith PF, Maclennan K, Darlington CL. The neuroprotective properties of the Gingko biloba leaf: a review of the possible relationship to platelet-activating factor (PAF). J Ethnopharmacol 1996; 50: 131-139
-
(1996)
J Ethnopharmacol
, vol.50
, pp. 131-139
-
-
Smith, P.F.1
Maclennan, K.2
Darlington, C.L.3
-
35
-
-
0022591674
-
Ginger: Inhibition of thromboxane synthetase and stimulation of prostacyclin: Relevance for medicine and psychiatry
-
Backon J. Ginger: inhibition of thromboxane synthetase and stimulation of prostacyclin: relevance for medicine and psychiatry. Med Hypotheses 1986; 20: 271-278
-
(1986)
Med Hypotheses
, vol.20
, pp. 271-278
-
-
Backon, J.1
-
36
-
-
0030968693
-
Chinese herbs and warfarin potentiation by "danshen"
-
Yu CM, Chan JC, Sanderson JE. Chinese herbs and warfarin potentiation by "danshen". J Intern med 1997; 241: 337-339
-
(1997)
J Intern Med
, vol.241
, pp. 337-339
-
-
Yu, C.M.1
Chan, J.C.2
Sanderson, J.E.3
-
37
-
-
0032868436
-
Potentiation of warfarin by dong quai
-
Page RL 2nd, Lawrence JD. Potentiation of warfarin by dong quai. Pharmacotherapy 1999; 19: 870-876
-
(1999)
Pharmacotherapy
, vol.19
, pp. 870-876
-
-
Page II, R.L.1
Lawrence, J.D.2
-
38
-
-
0031002860
-
Morreale AR Probable interactions between warfarin and ginseng
-
Janetzky K, Morreale AR Probable interactions between warfarin and ginseng. Am J Health Syst Pharm 1997; 54: 692-693
-
(1997)
Am J Health Syst Pharm
, vol.54
, pp. 692-693
-
-
Janetzky, K.1
-
39
-
-
0026766175
-
Modulators of coagulation. A critical appraisal of their role in sepsis
-
Bone RC. Modulators of coagulation. A critical appraisal of their role in sepsis. Arch Intern Med 1992; 152: 1381-1389
-
(1992)
Arch Intern Med
, vol.152
, pp. 1381-1389
-
-
Bone, R.C.1
-
40
-
-
0042487197
-
Biochemistry and function of platelets. Composition of platelets
-
Williams WJ, Beutler E, Erslev AJ, Lichtman MA (Hrsg). New York: McGraw Hill
-
Holmsen H. Biochemistry and function of platelets. Composition of platelets. In: Williams WJ, Beutler E, Erslev AJ, Lichtman MA (Hrsg). Hematology. New York: McGraw Hill, 1991: 1182-1200
-
(1991)
Hematology
, pp. 1182-1200
-
-
Holmsen, H.1
-
41
-
-
0019225742
-
2) inhibits the development in human platelets of ADP and arachidonic acid - Induced shape change and procoagulant activity
-
2) inhibits the development in human platelets of ADP and arachidonic acid - induced shape change and procoagulant activity. Prostaglandins 1980; 20: 1103-1116
-
(1980)
Prostaglandins
, vol.20
, pp. 1103-1116
-
-
Ehrman, M.E.1
Jaffe, E.A.2
-
42
-
-
0017639138
-
Activation of factor IX by the reaction product of tissue factor and factor VII: Additional pathway for initiating blood coagulation
-
Osterud B, Rapaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA 1977; 74: 5260-5264
-
(1977)
Proc Natl Acad Sci USA
, vol.74
, pp. 5260-5264
-
-
Osterud, B.1
Rapaport, S.I.2
-
43
-
-
0018938967
-
Kinetics of factor IX activation via the extrinsic pathway. Dependence of Km on tissue factor
-
Zur M, Nemerson Y. Kinetics of factor IX activation via the extrinsic pathway. Dependence of Km on tissue factor. J Biol Chem 1980; 255: 5703-5707
-
(1980)
J Biol Chem
, vol.255
, pp. 5703-5707
-
-
Zur, M.1
Nemerson, Y.2
-
44
-
-
0026741833
-
The role of leucocytes in the activation of blood coagulation
-
Edwards EL, Rickles FR. The role of leucocytes in the activation of blood coagulation. Semin Hematol 1992; 29: 202-212
-
(1992)
Semin Hematol
, vol.29
, pp. 202-212
-
-
Edwards, E.L.1
Rickles, F.R.2
-
45
-
-
0025967559
-
Heterogeneous regulation of constitutive thrombomodulin or inducible tissue-factor activities on the surface of human saphenous-vein endothelial cells in culture following stimulation by interleukin-1, tumour necrosis factor, thrombin or phorbol ester
-
Archipoff G, Beretz A, Freyssinet JM. Heterogeneous regulation of constitutive thrombomodulin or inducible tissue-factor activities on the surface of human saphenous-vein endothelial cells in culture following stimulation by interleukin-1, tumour necrosis factor, thrombin or phorbol ester. Biochem J 1991; 273: 679-684
-
(1991)
Biochem J
, vol.273
, pp. 679-684
-
-
Archipoff, G.1
Beretz, A.2
Freyssinet, J.M.3
-
46
-
-
0025793699
-
Endothelium and regulation of coagulation
-
Stern EM, Esposito C, Gerlach H, Gerlach M, Ryan J, Handley D, Nawroth P. Endothelium and regulation of coagulation. Diabetes Care 1991; 14: 160-166
-
(1991)
Diabetes Care
, vol.14
, pp. 160-166
-
-
Stern, E.M.1
Esposito, C.2
Gerlach, H.3
Gerlach, M.4
Ryan, J.5
Handley, D.6
Nawroth, P.7
-
47
-
-
0025806257
-
Role of leucocytes in the activation of intravascular coagulation in patients with septicemia
-
Okajima K, Wang YP, Okabe H, Inoue M, Takatsuki K. Role of leucocytes in the activation of intravascular coagulation in patients with septicemia. Am J Hematol 1991; 36: 265-271
-
(1991)
Am J Hematol
, vol.36
, pp. 265-271
-
-
Okajima, K.1
Wang, Y.P.2
Okabe, H.3
Inoue, M.4
Takatsuki, K.5
-
48
-
-
0012008473
-
Adhesive receptor Mac-1 coordinates the activation of factor X on stimulated cells of monocytic and myeloid differentiation: An alternative initiation of the coagulation protease cascade
-
Altieri DC, Morrissey JH, Edgington TS. Adhesive receptor Mac-1 coordinates the activation of factor X on stimulated cells of monocytic and myeloid differentiation: an alternative initiation of the coagulation protease cascade. Proc Natl Acad Sci USA 1988; 85: 7462-7466
-
(1988)
Proc Natl Acad Sci USA
, vol.85
, pp. 7462-7466
-
-
Altieri, D.C.1
Morrissey, J.H.2
Edgington, T.S.3
-
49
-
-
0025963529
-
Regulation of thrombomodulin by tumor necrosis factor-α: Comparison of transcriptional and posttranscriptional mechanisms
-
Lentz SR, Tsiang M, Sadler JE. Regulation of thrombomodulin by tumor necrosis factor-α: comparison of transcriptional and posttranscriptional mechanisms. Blood 1991; 77: 542-550
-
(1991)
Blood
, vol.77
, pp. 542-550
-
-
Lentz, S.R.1
Tsiang, M.2
Sadler, J.E.3
-
50
-
-
0023089665
-
Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro
-
Moore KL, Andreoli SP, Esmon NL, Esmon CT, Bang NU. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest 1987; 79: 124-130
-
(1987)
J Clin Invest
, vol.79
, pp. 124-130
-
-
Moore, K.L.1
Andreoli, S.P.2
Esmon, N.L.3
Esmon, C.T.4
Bang, N.U.5
-
51
-
-
0021958273
-
Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity
-
Sakata Y, Curriden S, Lawrence D, Griffin JH, Loskutoff DJ. Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity. Proc Natl Acad Sci USA 1985; 82: 1121-1125
-
(1985)
Proc Natl Acad Sci USA
, vol.82
, pp. 1121-1125
-
-
Sakata, Y.1
Curriden, S.2
Lawrence, D.3
Griffin, J.H.4
Loskutoff, D.J.5
-
52
-
-
0021732748
-
Membrane-bound enzyme complexes in blood coagulation
-
Spaet TH (Hrg). New York: Grune & Stratton
-
Mann KG. Membrane-bound enzyme complexes in blood coagulation. In: Spaet TH (Hrg). Progress in Hemostasis and Thrombosis. New York: Grune & Stratton, 1994: 1-23
-
(1994)
Progress in Hemostasis and Thrombosis
, pp. 1-23
-
-
Mann, K.G.1
-
53
-
-
0025170009
-
Heparin-like glycosaminoglycan is a receptor for antithrombin III-dependent but not thrombin-dependent prostacyclin production in human endothelial cells
-
Horie S, Ishii H, Kazama M. Heparin-like glycosaminoglycan is a receptor for antithrombin III-dependent but not thrombin - dependent prostacyclin production in human endothelial cells. Thromb Res 1990; 59: 895-904
-
(1990)
Thromb Res
, vol.59
, pp. 895-904
-
-
Horie, S.1
Ishii, H.2
Kazama, M.3
-
54
-
-
0025334367
-
Regulatory functions of the vascular endothelium
-
Vane JR, Änggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990; 323: 27-36
-
(1990)
N Engl J Med
, vol.323
, pp. 27-36
-
-
Vane, J.R.1
Änggard, E.E.2
Botting, R.M.3
-
55
-
-
0026704809
-
Regulation of blood coagulation by the protein C system
-
Walker FJ, Fay PJ. Regulation of blood coagulation by the protein C system. FASEB J 1992; 6: 2561-2567
-
(1992)
FASEB J
, vol.6
, pp. 2561-2567
-
-
Walker, F.J.1
Fay, P.J.2
-
56
-
-
4344611353
-
Gerinnung
-
Kochs E, Krier C, Buzello W, Adams HA (Hrsg). Stuttgart: Thieme
-
Scherer R. Gerinnung. In: Kochs E, Krier C, Buzello W, Adams HA (Hrsg). Anästhesiologie. 1. Aufl. Stuttgart: Thieme, 2001: 143-149
-
(2001)
Anästhesiologie. 1. Aufl.
, pp. 143-149
-
-
Scherer, R.1
-
57
-
-
4344620499
-
Plasmatische gerinnungsstörungen mit blutungsneigung
-
Van Aken, Reinhart K, Zimpfer M (Hrsg). Stuttgart: Thieme
-
Scherer R. Plasmatische Gerinnungsstörungen mit Blutungsneigung. In: Van Aken, Reinhart K, Zimpfer M (Hrsg). Intensivmedizin. 1. Aufl. Stuttgart: Thieme, 2001: 589-595
-
(2001)
Intensivmedizin. 1. Aufl.
, pp. 589-595
-
-
Scherer, R.1
-
58
-
-
0031975632
-
Procoagulant activity in patients with isolated severe head trauma
-
Scherer RU, Spangenberg P. Procoagulant activity in patients with isolated severe head trauma. Crit Care Med 1998; 26: 49-156
-
(1998)
Crit Care Med
, vol.26
, pp. 49-156
-
-
Scherer, R.U.1
Spangenberg, P.2
-
59
-
-
0141737604
-
Perioperative use of the thrombelastograph in patients with inherited bleeding disorders
-
Pivalizza EG. Perioperative use of the thrombelastograph in patients with inherited bleeding disorders. J Clin Anesth 2003; 15: 366-370
-
(2003)
J Clin Anesth
, vol.15
, pp. 366-370
-
-
Pivalizza, E.G.1
-
60
-
-
1542753652
-
Perioperative hypothermia in the high-risk surgical patient
-
Leslie K, Sessler DI. Perioperative hypothermia in the high-risk surgical patient. Best Pract Res Clin Anaesthesiol 2003; 17: 485-498
-
(2003)
Best Pract Res Clin Anaesthesiol
, vol.17
, pp. 485-498
-
-
Leslie, K.1
Sessler, D.I.2
-
61
-
-
0026490262
-
Antithrombin III supplementation during orthotopic liver transplantation in cirrhotic patients: A randomized trial
-
Baudo F, de Gasperi A, de Cataldo F et al. Antithrombin III supplementation during orthotopic liver transplantation in cirrhotic patients: a randomized trial. Thromb Res 1992; 68: 409-416
-
(1992)
Thromb Res
, vol.68
, pp. 409-416
-
-
Baudo, F.1
De Gasperi, A.2
De Cataldo, F.3
-
62
-
-
0027273604
-
Controlled trial of antithrombin III supplementation in ful-minant hepatic failure
-
Langley PG, Hughes RD, Forbes A et al. Controlled trial of antithrombin III supplementation in ful-minant hepatic failure. J Hepatol 1993; 17: 326-331
-
(1993)
J Hepatol
, vol.17
, pp. 326-331
-
-
Langley, P.G.1
Hughes, R.D.2
Forbes, A.3
-
63
-
-
0019994661
-
Antithrombin III transfusion in patients with hepatic cirrhosis
-
Schipper HG, Ten Cate JW. Antithrombin III transfusion in patients with hepatic cirrhosis. Br J Haematol 1982; 52: 25-33
-
(1982)
Br J Haematol
, vol.52
, pp. 25-33
-
-
Schipper, H.G.1
Ten Cate, J.W.2
-
64
-
-
0028949967
-
Antithrombin III concentrates - Are they clinically useful?
-
Lechner K, Kyrle PA. Antithrombin III concentrates - are they clinically useful? Thromb Haemostas 1995; 73: 340-348
-
(1995)
Thromb Haemostas
, vol.73
, pp. 340-348
-
-
Lechner, K.1
Kyrle, P.A.2
-
65
-
-
0027285968
-
Multiorganversagen nach Gabe von PPSB beim isolierten Faktor VII-Mangel
-
Heinemann H, Schramm W, Hoffmann P, Lierz P. Multiorganversagen nach Gabe von PPSB beim isolierten Faktor VII-Mangel. Anästh Intensivmed 1993; 34: 130-133
-
(1993)
Anästh Intensivmed
, vol.34
, pp. 130-133
-
-
Heinemann, H.1
Schramm, W.2
Hoffmann, P.3
Lierz, P.4
-
66
-
-
0033933019
-
Screening tests of disseminated intravascular coagulation: Guidelines for rapid and specific laboratory diagnoses
-
Yu M, Nardella A, Pechet L. Screening tests of disseminated intravascular coagulation: guidelines for rapid and specific laboratory diagnoses. Crit Care Med 1980; 28: 1777-1780
-
(1980)
Crit Care Med
, vol.28
, pp. 1777-1780
-
-
Yu, M.1
Nardella, A.2
Pechet, L.3
-
67
-
-
0142059999
-
Diagnostik und therapie von komplexen gerinnungsstörungen in der operativen intensivmedizin
-
Schroeder S, Wichers M, Lier H. Diagnostik und Therapie von komplexen Gerinnungsstörungen in der operativen Intensivmedizin. Anaesth Intensivmedizin 2003; 44: 668-679
-
(2003)
Anaesth Intensivmedizin
, vol.44
, pp. 668-679
-
-
Schroeder, S.1
Wichers, M.2
Lier, H.3
-
68
-
-
0028298594
-
Diagnose und therapie pathologischer gerinnungsaktivierungen
-
Scherer R, Paar D, Stöcker L, Kox W. Diagnose und Therapie pathologischer Gerinnungsaktivierungen. Anästhesist 1994; 43: 347-354
-
(1994)
Anästhesist
, vol.43
, pp. 347-354
-
-
Scherer, R.1
Paar, D.2
Stöcker, L.3
Kox, W.4
-
70
-
-
4344688530
-
The thrombogenetic agent in prothrombin complex concentrates (PCC): Identification of elevated levels of prothrombin as the major cause
-
König H, Hanker-Dusel C, Eich S, Grundmann C, Seitz R. The thrombogenetic agent in prothrombin complex concentrates (PCC): Identification of elevated levels of prothrombin as the major cause. Thromb Haemost 2003; 90 Suppl 1: S16-S48
-
(2003)
Thromb Haemost
, vol.90
, Issue.SUPPL.
-
-
König, H.1
Hanker-Dusel, C.2
Eich, S.3
Grundmann, C.4
Seitz, R.5
-
71
-
-
0043269380
-
Hämostaseologische aspekte des perioperativen blutmanagements
-
Scherer RU, Hämostaseologische Aspekte des perioperativen Blutmanagements. Zentralbl Chir 2003; 128: 473-480
-
(2003)
Zentralbl Chir
, vol.128
, pp. 473-480
-
-
Scherer, R.U.1
-
72
-
-
0036284022
-
Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: Implications of a prospective study
-
Gerlach R, Tolle F, Raabe A, Zimmermann M, Siegemund A, Seifert V. Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: implications of a prospective study. Stroke 2002; 33: 1618-1623
-
(2002)
Stroke
, vol.33
, pp. 1618-1623
-
-
Gerlach, R.1
Tolle, F.2
Raabe, A.3
Zimmermann, M.4
Siegemund, A.5
Seifert, V.6
-
74
-
-
0036280855
-
Rekombinanter faktor VIIa. Ein überblick über aktuelle und mögliche zukünftige indikationen
-
Heuer L, Blumenberg D. Rekombinanter Faktor VIIa. Ein Überblick über aktuelle und mögliche zukünftige Indikationen. Anaesthesist 2002; 51: 388-399
-
(2002)
Anaesthesist
, vol.51
, pp. 388-399
-
-
Heuer, L.1
Blumenberg, D.2
-
75
-
-
0030695063
-
Platelet activity of high-dose factor VIIa is independent of tissue factor
-
Monroe DM, Hoffmann M, Oliver JA, Roberts HR. Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol 1997; 99: 542-547
-
(1997)
Br J Haematol
, vol.99
, pp. 542-547
-
-
Monroe, D.M.1
Hoffmann, M.2
Oliver, J.A.3
Roberts, H.R.4
-
76
-
-
0032560732
-
Hemostatic drugs
-
Mannucci PM. Hemostatic drugs. N Engl J Med 1998; 339: 245-253
-
(1998)
N Engl J Med
, vol.339
, pp. 245-253
-
-
Mannucci, P.M.1
-
77
-
-
0033524140
-
Pharmacological strategies to decrease excessive blood loss in cardiac surgery: A meta-analysis of clinically relevant endpoints
-
Levi M, Cromheecke ME, de Jonge E, Prins MH, de Mol BJ, Briet E, Buller HR. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet 1999; 354: 1940-1947
-
(1999)
Lancet
, vol.354
, pp. 1940-1947
-
-
Levi, M.1
Cromheecke, M.E.2
De Jonge, E.3
Prins, M.H.4
De Mol, B.J.5
Briet, E.6
Buller, H.R.7
-
78
-
-
0036521240
-
Does tranexamic acid reduce desmopressin-induced hyperfibrinolysis?
-
Ozal E, Kuralay E, Bingol H, Cingoz F, Ceylan S, Tatar H. Does tranexamic acid reduce desmopressin-induced hyperfibrinolysis? J Thorac Cardiovasc Surg 2002; 123: 539-543
-
(2002)
J Thorac Cardiovasc Surg
, vol.123
, pp. 539-543
-
-
Ozal, E.1
Kuralay, E.2
Bingol, H.3
Cingoz, F.4
Ceylan, S.5
Tatar, H.6
|